Antiaging Quantum Living Inc.
AAQL
$0.60
-$0.12-16.97%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 147.28% | 194.63% | 335.36% | 10,806.67% | 5,989.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 147.28% | 194.63% | 335.36% | 10,806.67% | 5,989.66% |
| Cost of Revenue | 3,074.24% | 3,129.22% | 44,500.00% | 48,587.50% | 2,375.00% |
| Gross Profit | 33.65% | 71.22% | 122.42% | 6,295.52% | 6,355.70% |
| SG&A Expenses | -4.31% | 5.08% | 46.10% | 190.30% | 731.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.17% | 46.85% | 101.27% | 282.35% | 739.02% |
| Operating Income | 26.52% | 26.34% | -19.59% | -91.26% | -450.69% |
| Income Before Tax | 21.47% | 36.74% | -6.15% | -74.43% | -406.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.41% | 34.61% | -7.15% | -74.43% | -406.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.41% | 34.61% | -7.15% | -74.43% | -406.69% |
| EBIT | 26.52% | 26.34% | -19.59% | -91.26% | -450.69% |
| EBITDA | 36.46% | 39.93% | 2.67% | -59.06% | -379.13% |
| EPS Basic | 20.97% | 34.38% | -7.58% | -75.18% | -413.46% |
| Normalized Basic EPS | 23.21% | 36.65% | -5.60% | -74.42% | -409.09% |
| EPS Diluted | 20.97% | 34.38% | -7.58% | -75.18% | -413.46% |
| Normalized Diluted EPS | 23.21% | 36.65% | -5.60% | -74.42% | -409.09% |
| Average Basic Shares Outstanding | 1.47% | 0.04% | -0.04% | -0.04% | -0.04% |
| Average Diluted Shares Outstanding | 1.47% | 0.04% | -0.04% | -0.04% | -0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |